Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cidara Therapeutics
Biotech
Janssen sticks with Cidara's flu med, but plans to sell it off
Janssen's R&D overhaul has not stopped it from moving forward with Cidara's flu med; however, the Big Pharma plans to offload rights.
Max Bayer
Sep 6, 2023 11:39am
3 Flagship biotechs make key exec hires—Chutes & Ladders
Aug 18, 2023 9:30am
Janssen's infectious disease partners left in the lurch
Jul 21, 2023 10:14am
Cidara wins near-unanimous AdComm support despite data doubts
Jan 25, 2023 10:17am
Melinta pays Cidara $30M for antifungal pending FDA review
Jul 27, 2022 11:05am
Romanelli returns to Merck after brief CEO role—Chutes & Ladders
Apr 22, 2022 9:30am